Breaking Down Inari Medical: 9 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
Inari Medical (NASDAQ:NARI) received mixed analyst ratings, with a slight downward trend in price targets. Analysts set a 12-month average price target of $58.78, down 2.31% from the previous $60.17. The company shows strong revenue growth but faces challenges in profitability and asset utilization.
October 09, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inari Medical received mixed analyst ratings, with a slight downward trend in price targets. Analysts set a 12-month average price target of $58.78, down 2.31% from the previous $60.17. The company shows strong revenue growth but faces challenges in profitability and asset utilization.
The mixed analyst ratings and slight decrease in price targets suggest a neutral short-term impact on Inari Medical's stock price. While the company shows strong revenue growth, challenges in profitability and asset utilization may offset positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100